A Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects With Locally Advanced Unresectable or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Clinical trial NCT04086758 · COMPLETED
Trial details
- NCT number
- NCT04086758
- Sponsor
- Astellas Pharma China, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-18
- Primary completion
- 2021-01-22
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.